Fumaric acid esters in the management of psoriasis
Deepak MW Balak Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands Abstract: Fumaric acid esters (FAE) are small molecules with immunomodulating, anti-inflammatory, and anti-oxidative effects. FAE were introduced as a systemic psoriasis treatment in 1959 and empirically de...
Saved in:
Main Author: | Balak DMW (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fumaric acid esters in dermatology
by: Uwe Wollina
Published: (2011) -
Drug-induced psoriasis: clinical perspectives
by: Balak DMW, et al.
Published: (2017) -
Do NSAIDs Trigger or Exacerbate Psoriasis? [Response to Letter]
by: Balak DMW, et al.
Published: (2024) -
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
by: Balak DMW, et al.
Published: (2021) -
Discontinuation of Fumaric Acid Esters is Affected by Depressive Symptomatology: A Retrospective Analysis
by: Frederik Krefting, et al.
Published: (2024)